The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Pharmacology and potential therapeutic applications of nitric oxide‐releasing non‐steroidal anti‐inflammatory and related nitric oxide‐donating drugs
Open accessAbstract
This review examines the biological significance, therapeutic potential and mechanism(s) of action of a range of nitric oxide‐releasing non‐steroidal anti‐inflammatory drugs (NO‐NSAID) and related nitric oxide‐releasing donating drugs (NODD). The slow release of nitric oxide (NO) from these compounds leads to subtle changes in the profile of pharmacological activity of the parent, non‐steroidal anti‐inflammatory drugs (NSAID). For example, compared with NSAID, NO‐NSAID cause markedly diminished gastrointestinal toxicity and improved anti‐inflammatory and anti‐nociceptive efficacy. In addition, nitroparacetamol exhibits hepatoprotection as opposed to the hepatotoxic activity of paracetamol. The possibility that NO‐NSAID or NODD may be of therapeutic benefit in a wide variety of disease states including pain and inflammation, thrombosis and restenosis, neurodegenerative diseases of the central nervous system, colitis, cancer, urinary incontinence, liver disease, impotence, bronchial asthma and osteoporosis is discussed. British Journal of Pharmacology (2002) 137, 295–310. doi:10.1038/sj.bjp.0704876
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Oral Sildenafil in the Treatment of Erectile Dysfunction
Goldstein, I., Lue, T. F., Padma-Nathan, H., Rosen, R. C., Steers, W. D., & Wicker, P. A. (1998) · New England Journal of Medicine · doi:10.1056/nejm199805143382001 · Cited by 2,120
Export by red blood cells of nitric oxide bioactivity
Pawloski, J. R., Hess, D. T., & Stamler, J. S. (2001) · Nature · doi:10.1038/35054560 · Cited by 579
Van'T Hof, R. J., & Ralston, S. H. (2001) · Immunology · doi:10.1046/j.1365-2567.2001.01261.x · Cited by 518
Goulis, J., Leandro, G., & Burroughs, A. K. (1999) · The Lancet · doi:10.1016/s0140-6736(98)11293-x · Cited by 315 · cited 1×
“…with this drug in the clinic does not prevent continuing bile duct destruction or the histological, virological and biochemical impairment of liver function in patients with primary biliary cirrhosis or British Journal of Pharmacology vol 137 (3) virus-induced hepatitis C (Goulis et al., 1999).”
Background
Cited by
Nitric oxide in health and disease of the respiratory system
Ricciardolo, F. L. M., Sterk, P. J., Gaston, B., & Folkerts, G. (2004) · Physiological Reviews · doi:10.1152/physrev.00034.2003 · Cited by 903
Immune and inflammatory mechanisms in neuropathic pain
Moalem, G., & Tracey, D. J. (2006) · Brain Research Reviews · doi:10.1016/j.brainresrev.2005.11.004 · Cited by 774
Use of NSAIDs in treating patients with arthritis
Crofford, L. J. (2013) · Arthritis Research & Therapy · doi:10.1186/ar4174 · Cited by 650
Recent developments in nitric oxide donor drugs
Miller, M. R., & Megson, I. L. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707224 · Cited by 628
Paracetamol (Acetaminophen): mechanisms of action
ANDERSON, B. J. (2008) · Pediatric Anesthesia · doi:10.1111/j.1460-9592.2008.02764.x · Cited by 497
Anti-Inflammatory Drugs in the 21st Century
Rainsford, K. D. (2007) · Subcellular Biochemistry · doi:10.1007/1-4020-5688-5_1 · Cited by 463
Clinical Pharmacology of Non-Steroidal Anti-Inflammatory Drugs: A Review
Bacchi, S., Palumbo, P., Sponta, A., & Coppolino, M. F. (2012) · Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry · doi:10.2174/187152312803476255 · Cited by 433
Cyclic GMP signaling in cardiovascular pathophysiology and therapeutics
Tsai, E. J., & Kass, D. A. (2009) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2009.02.009 · Cited by 420
Anti-inflammatory and gastrointestinal effects of a novel diclofenac derivative
Li, L., Rossoni, G., Sparatore, A., Lee, L. C., Del Soldato, P., & Moore, P. K. (2007) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2006.12.011 · Cited by 345
Self-citationLi, L., Hsu, A., & Moore, P. K. (2009) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2009.05.005 · Cited by 331
Self-citationSohail, R., Mathew, M., Patel, K. K., Reddy, S. A., Haider, Z., Naria, M., Habib, A., Abdin, Z. U., Razzaq Chaudhry, W., & Akbar, A. (2023) · Cureus · doi:10.7759/cureus.37080 · Cited by 239
Nitric oxide donor drugs: an update on pathophysiology and therapeutic potential
Scatena, R., Bottoni, P., Martorana, G. E., & Giardina, B. (2005) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.14.7.835 · Cited by 74
“In fact, NO release in gastrointestinal mucosa antagonises the effect of cyclooxygenase (COX) inhibition by NSAIDs in different ways: for example, the induction of mucosal vasodilation; inhibition of leukocyte adhesion and margination; and inhibition of mucosal cell apoptosis mediated by caspase inactivation [65].”
BackgroundInfluentialMaksimovic-Ivanic, D., Mijatovic, S., Harhaji, L., Miljkovic, D., Dabideen, D., Fan Cheng, K., Mangano, K., Malaponte, G., Al-Abed, Y., Libra, M., et al. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-2037 · Cited by 74
Metadata
- Authors
- Keeble, J. E., & Moore, P. K.
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 2002-10
- Volume
- 137
- Issue
- 3
- Pages
- 295-310
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- OpenAlex
- W2022325044
- Cited by
- 187
- References
- 4
- FWCI
- 7.46
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.